## Abstract The anterior cingulate (AC) gyrus and the presupplementary motor area (pre‐SMA) show pathological changes in Parkinson's disease (PD). We examined if PD patients show magnetic resonance spectroscopy (MRS) changes in NAA/Cr in the AC, pre‐SMA, or posterior cingulate (PC). Forty‐four (27
Intact presupplementary motor area function in early, untreated Parkinson's disease
✍ Scribed by W. R. Wayne Martin; Marguerite Wieler; Myrlene Gee; Christopher C. Hanstock; Richard M. Camicioli
- Book ID
- 102945220
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 641 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Although motor symptoms of Parkinson's disease (PD) are initially responsive to dopamine replacement therapy, nonresponsive features develop over time, suggesting that impaired dopaminergic function alone may not be wholly responsible for all the motor features of the disease. Previous studies suggest impaired function in the presupplementary motor area (pre‐SMA) in PD. Our objective was to determine whether pre‐SMA abnormalities are present in untreated patients with early disease. We measured N‐acetyl aspartate (NAA)/creatine (Cr) and choline (Cho)/Cr ratios in pre‐SMA in 26 untreated patients with early PD (disease duration 3.0 ± 2.0 yr) and 15 control subjects with single voxel magnetic resonance spectroscopy. Neither NAA/Cr nor Cho/Cr ratios differed significantly between groups. These observations suggest that, although pre‐SMA function is impaired in moderately advanced PD, it is relatively spared in early disease. We suggest that pre‐SMA dysfunction is in part responsible for the dopamine nonresponsive features associated with disease progression. © 2008 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract The purpose of this study was to determine if focal cortical abnormalities may occur in early Parkinson's disease (PD). We studied 26 untreated patients with early PD and 14 healthy control subjects, with cognitive screening and magnetic resonance imaging (MRI). Voxel‐based morphometry
## Abstract The diagnosis of Parkinson's disease rests on motor signs of advanced central dopamine deficiency. There is an urgent need for disease biomarkers. Clinicopathological evidence suggests that α‐synuclein aggregation, the pathological signature of Parkinson's disease, can be detected in ga